Bridget E. Bunner

Array ( [id] => 9008933 [patent_doc_number] => 08524227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Anti-IL-TIF antibodies' [patent_app_type] => utility [patent_app_number] => 12/732116 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 65125 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12732116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097431 [patent_doc_number] => 20110003743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/726468 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16583 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003743.pdf [firstpage_image] =>[orig_patent_app_number] => 12726468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097431 [patent_doc_number] => 20110003743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/726468 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16583 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003743.pdf [firstpage_image] =>[orig_patent_app_number] => 12726468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783902 [patent_doc_number] => 20120045458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'USE OF NOTCH REGULATORS FOR MODULATING THE IMMUNE RESPONSE BY INDUCTION/SUPPRESSION OF INTERLEUKIN-22' [patent_app_type] => utility [patent_app_number] => 13/201638 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3883 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045458.pdf [firstpage_image] =>[orig_patent_app_number] => 13201638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644576 [patent_doc_number] => 08022182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Truncated BAFF receptors' [patent_app_type] => utility [patent_app_number] => 12/704190 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 11584 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022182.pdf [firstpage_image] =>[orig_patent_app_number] => 12704190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732335 [patent_doc_number] => 20120015352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD OF DETERMINING SENSITIVITY OF HUMAN OR NON-HUMAN ANIMAL CELLS TO AN IAP ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 13/146817 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15390 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015352.pdf [firstpage_image] =>[orig_patent_app_number] => 13146817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920485 [patent_doc_number] => 08486416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Use of SDF-1 to improve ischemic myocardial function' [patent_app_type] => utility [patent_app_number] => 12/657264 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 53 [patent_no_of_words] => 17517 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12657264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631951 [patent_doc_number] => 20100173331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'NOVEL NOTCH-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/650211 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7429 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173331.pdf [firstpage_image] =>[orig_patent_app_number] => 12650211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228968 [patent_doc_number] => 20100183706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'PEPTIDE EPITOPES OF APOLIPOPROTEIN B' [patent_app_type] => utility [patent_app_number] => 12/644810 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11474 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183706.pdf [firstpage_image] =>[orig_patent_app_number] => 12644810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401029 [patent_doc_number] => 20100179094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'BISPECIFIC EGFR/IGFIR BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/625217 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 62313 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179094.pdf [firstpage_image] =>[orig_patent_app_number] => 12625217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566853 [patent_doc_number] => 20110286916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'GENERATION AND CHARACTERIZATION OF ANTI-NOTCH ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC USE' [patent_app_type] => utility [patent_app_number] => 13/130441 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 106122 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20110286916.pdf [firstpage_image] =>[orig_patent_app_number] => 13130441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686000 [patent_doc_number] => 20100120141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Screening methods for compounds that modulate the activity of G-protein coupled receptors' [patent_app_type] => utility [patent_app_number] => 12/616361 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12212 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120141.pdf [firstpage_image] =>[orig_patent_app_number] => 12616361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555334 [patent_doc_number] => 08067235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Optimized human T1R2 nucleic acid molecule' [patent_app_type] => utility [patent_app_number] => 12/616340 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12209 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067235.pdf [firstpage_image] =>[orig_patent_app_number] => 12616340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697146 [patent_doc_number] => 20110229444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Neuregulin And Cardiac Stem Cells' [patent_app_type] => utility [patent_app_number] => 13/131668 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9426 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229444.pdf [firstpage_image] =>[orig_patent_app_number] => 13131668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6400790 [patent_doc_number] => 20100305003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590442 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47743 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305003.pdf [firstpage_image] =>[orig_patent_app_number] => 12590442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596955 [patent_doc_number] => 20100292155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590409 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47739 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292155.pdf [firstpage_image] =>[orig_patent_app_number] => 12590409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236336 [patent_doc_number] => 20100267648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590236 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267648.pdf [firstpage_image] =>[orig_patent_app_number] => 12590236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8737800 [patent_doc_number] => 08409567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Toll-like receptor 3 antagonists' [patent_app_type] => utility [patent_app_number] => 12/609675 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 34 [patent_no_of_words] => 28940 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12609675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6510287 [patent_doc_number] => 20100261194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/610128 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162804 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261194.pdf [firstpage_image] =>[orig_patent_app_number] => 12610128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521121 [patent_doc_number] => 07951381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor' [patent_app_type] => utility [patent_app_number] => 12/589727 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 141 [patent_no_of_words] => 69602 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951381.pdf [firstpage_image] =>[orig_patent_app_number] => 12589727 [rel_patent_id] =>[rel_patent_doc_number] =>)